# ALX Oncology Holdings Inc: Form SC 13D/A, filed Feb 14, 2024

- Company: [ALX Oncology Holdings Inc](/companies/alxo.md) (CIK 1810182)
- Form: SC 13D/A
- Filed: 2024-02-14
- Accepted by EDGAR: Feb 15, 2024, 00:28 ET
- Period: not reported
- Accession: 0001104659-24-024164
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1810182/000110465924024164/tm246244d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810182/000110465924024164/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810182/000110465924024164/tm246244d1_sc13da.htm

Filed Feb 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-024164. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.